|
|
Regel 1: |
Regel 1: |
| | | |
| __NUMBEREDHEADINGS__ | | __NUMBEREDHEADINGS__ |
| + | {{#customtitle:Sturen medicatievoorschrift 9.0.7: addendum inhoudelijke gegevens kwalificatie}} |
| [[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]] | | [[Bestand:Nictiz_logo_PO_rechts_rgb.png |link=https://www.nictiz.nl/|rechts|Naar nictiz.nl]] |
| | | |
| =Addenda voor inhoudelijke gegevens= | | =Addenda voor inhoudelijke gegevens= |
− | ===Patiënt I. XXX_Jangi===
| + | ==Patiënt A. Basis patient A== |
− | <section begin=XXX_Jangi /> | + | <section begin=Basis patient A /> |
| {| class="wikitable" width="85%" | | {| class="wikitable" width="85%" |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Patiënt | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Patiënt |
| |-style="background-color: #1F497D;; color: white; text-align:left;" | | |-style="background-color: #1F497D;; color: white; text-align:left;" |
− | |colspan="3" width="25%"| Gegevenselement | + | |colspan="2" width="25%"| Gegevenselement |
| || Waarde | | || Waarde |
| | | |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="3"|Naamgegevens | + | |colspan="2"|Naamgegevens |
− | |style="background-color: white;"|I. XXX_Jangi | + | |style="background-color: white;"|A. Basis patient A |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Adresgegevens
| |
− | |style="background-color: white;"|Knolweg 1002 9999ZZ Stitswerd 3 Woon-/verblijfadres
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Telefoonnummers
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |rowspan="3"| | + | |colspan="2"|Identificatienummer |
| + | |style="background-color: white;"|999911326 [BSN] |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="2"|Telefoonnummer | + | |colspan="2"|Identificatienummer |
− | |style="background-color: white;"|+31612345678 | + | |style="background-color: white;"|11101 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1' |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="2"|Nummer soort | + | |colspan="2"|Geboortedatum |
− | |style="background-color: white;"|Telefoonnummer thuis (code = 'HP' in codeSystem 'HL7 AddressUse') | + | |style="background-color: white;"|1 aug 1964 |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="3"|Identificatienummer | + | |colspan="2"|Geslacht |
− | |style="background-color: white;"|999911727 [BSN]
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Identificatienummer
| |
− | |style="background-color: white;"|10009 met root OID '2.16.840.1.113883.2.4.3.11.999.77.19829.1'
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geboortedatum
| |
− | |style="background-color: white;"|2 aug 1964
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Geslacht
| |
| |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end=XXX_Jangi /><section begin=DG_XXX_Jangi /> | + | |}<section end=Basis patient A /> |
− | ====Documentgegevens XXX_Jangi ==== | + | ===Medicatieafspraken Basis patient A === |
− | | + | <section begin=MA_Basis patient A /> |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Documentgegevens
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Document datum
| |
− | |style="background-color: white;"|16 aug 2018
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Auteur - zorgaanbieder
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="11"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Organisatie naam
| |
− | |style="background-color: white;"|Apotheek de Gulle Gaper
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Adresgegevens
| |
− | |style="background-color: white;"|Zalfstraat 6 1235BB Ons Dorp 5 Werkadres
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Telefoonnummers
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Telefoonnummer
| |
− | |style="background-color: white;"|+31703655424
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Nummer soort
| |
− | |style="background-color: white;"|Zakelijk telefoonnummer (code = 'WP' in codeSystem 'HL7 AddressUse')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Email adressen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Email adres
| |
− | |style="background-color: white;"|info@apotheekgullegaper.com
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="2"|Email soort
| |
− | |style="background-color: white;"|Zakelijk e-mailadres (code = 'WP' in codeSystem 'HL7 AddressUse')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Verificatie patient
| |
− | |style="background-color: white;"|Nee
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Verificatie zorgverlener
| |
− | |style="background-color: white;"|Nee
| |
− | |}<section end=DG_XXX_Jangi /><section begin=MBHS_XXX_Jangi /><section begin=MBH_MBH_MO_123_1 />
| |
− | ====Medicamenteuze behandeling MBH_MO_123_1 ====
| |
− | | |
| {| class="wikitable" width="85%" | | {| class="wikitable" width="85%" |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatie gebruik
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatieafspraak |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_1_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Registratiedatum
| |
− | |style="background-color: white;"|T, om 10:57
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruik indicator
| |
− | |style="background-color: white;"|Ja
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksperiode
| |
− | |style="background-color: white;"|Vanaf T- 3 dagen, gedurende 3 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Geneesmiddel - Product specificatie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Product naam
| |
− | |style="background-color: white;"|Ibuprofen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T- 3 dagen, gedurende 3 dagen, 4 maal per dag 1 tablet, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Doseerinstructie
| |
− | |style="background-color: white;"|4 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |style="background-color: white;"|Patiënt
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Kopie indicator
| |
− | |style="background-color: white;"|Ja
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Toelichting
| |
− | |style="background-color: white;"|Pijn
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}<section end=MBH_MBH_MO_123_1 /><section begin=MBH_MBH_MO_123_2 />
| |
− | ====Medicamenteuze behandeling MBH_MO_123_2 ====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Toedieningsafspraak | |
| |-style="background-color: #1F497D;; color: white; text-align:left;" | | |-style="background-color: #1F497D;; color: white; text-align:left;" |
| |colspan="5" width="25%"| Gegevenselement | | |colspan="5" width="25%"| Gegevenselement |
Regel 152: |
Regel 39: |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="5"|Identificatie | | |colspan="5"|Identificatie |
− | |style="background-color: white;"|MBH_MO_123_2_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_VO_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="5"|Afspraakdatum | | |colspan="5"|Afspraakdatum |
− | |style="background-color: white;"|T- 6 dagen, om 11:55 | + | |style="background-color: white;"|20 jun 2019, om 11:25 |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="5"|Gebruiksperiode | | |colspan="5"|Gebruiksperiode |
− | |style="background-color: white;"|Vanaf T- 6 dagen, tot nader order | + | |style="background-color: white;"|Vanaf 20 jun 2019, tot en met 25 jun 2019, om 00:00 |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="6"|Verstrekker | + | |colspan="6"|Voorschrijver |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |rowspan="5"| | + | |rowspan="11"| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="5"|Zorgaanbieder | + | |colspan="5"|Zorgverlener |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |rowspan="3"| | + | |rowspan="9"| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="3"|Zorgaanbieder identificatie nummer | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="3"|Organisatie naam | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"|Apotheek De Gulle Gaper | + | |style="background-color: white;"|Peter van Pulver |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="5"|Geneesmiddel - primaire code | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"|Emovate zalf 0,5 mg/g (code = '400629' in codeSystem 'G-Standaard HPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|CLOBETASON ZALF 0,5MG/G (code = '65617' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|CLOBETASON ZALF 0,5MG/G (code = '115606' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="6"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T- 6 dagen, tot nader order, eerst 2 maal per dag zalf gedurende 7 dagen, daarna 1 maal per dag zalf gedurende 7 dagen, daarna 3 maal per week zalf gedurende 7 dagen, cutaan
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Toedieningsweg
| |
− | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Doseerinstructie 1
| |
− | |style="background-color: white;"|eerst gedurende 7 dagen 2 maal per dag
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Doseerinstructie 2
| |
− | |style="background-color: white;"|dan gedurende 7 dagen 1 maal per dag
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Doseerinstructie 3
| |
− | |style="background-color: white;"|dan gedurende 7 dagen 3 maal per week
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Toelichting
| |
− | |style="background-color: white;"|Eczeem oogleden
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}<section end=MBH_MBH_MO_123_2 /><section begin=MBH_MBH_MO_123_3 />
| |
− | ====Medicamenteuze behandeling MBH_MO_123_3 ====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="7" | Medicatieafspraak
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="6" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_3_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Afspraakdatum
| |
− | |style="background-color: white;"|T- 15 dagen, om 09:13
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Gebruiksperiode
| |
− | |style="background-color: white;"|Vanaf T- 15 dagen, gedurende 4 weken
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="7"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="10"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Zorgverlener
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="8"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Naamgegevens
| |
− | |style="background-color: white;"|John de Vries
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Specialisme
| |
| |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="5"|Zorgaanbieder | + | |colspan="4"|Zorgaanbieder |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |rowspan="4"| | | |rowspan="4"| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="3"|Zorgaanbieder identificatienummer | + | |colspan="2"|Zorgaanbieder identificatienummer |
| |style="background-color: white;"|00001111 (in identificerend systeem: URA) | | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="3"|Organisatie naam | + | |colspan="2"|Organisatie naam |
| |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="3"|Adresgegevens | + | |colspan="2"|Adresgegevens |
| |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|GLIMEPIRIDE TABLET 3MG (code = '44458' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|GLIMEPIRIDE TABLET 3MG (code = '98345' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="7"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T- 15 dagen, gedurende 4 weken, 1 maal per dag 2 tabletten, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 2 stuks
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Kopie indicator
| |
− | |style="background-color: white;"|Ja
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Toelichting
| |
− | |style="background-color: white;"|Exact 4 weken
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Toedieningsafspraak
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="5" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_3_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Afspraakdatum
| |
− | |style="background-color: white;"|T- 14 dagen, om 15:55
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Gebruiksperiode
| |
− | |style="background-color: white;"|Vanaf T- 14 dagen, tot en met T+ 13 dagen, om 23:59
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="5"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Zorgaanbieder
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgaanbieder identificatie nummer
| |
− | |style="background-color: white;"|01236578 (in identificerend systeem: URA)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Organisatie naam
| |
− | |style="background-color: white;"|Apotheek De Gulle Gaper
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="5"|Geneesmiddel - primaire code | | |colspan="5"|Geneesmiddel - primaire code |
− | |style="background-color: white;"|Glimepiride activis tablet 3mg (code = '1753029' in codeSystem 'G-Standaard HPK') | + | |style="background-color: white;"|Metoclopramide zetpil 20mg (code = '6939' in codeSystem 'G-Standaard PRK') |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|GLIMEPIRIDE TABLET 3MG (code = '44458' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="5"|Geneesmiddel - generiekere code | | |colspan="5"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"|GLIMEPIRIDE TABLET 3MG (code = '98345' in codeSystem 'G-Standaard GPK') | + | |style="background-color: white;"|METOCLOPRAMIDE 20MG ZETPIL (code = '63630' in codeSystem 'G-Standaard GPK') |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="6"|Gebruiksinstructie | | |colspan="6"|Gebruiksinstructie |
Regel 325: |
Regel 88: |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="4"|Omschrijving | | |colspan="4"|Omschrijving |
− | |style="background-color: white;"|Vanaf T- 14 dagen, tot en met T+ 13 dagen, om 23:59, 1 maal per dag 2 tabletten, oraal | + | |style="background-color: white;"|Vanaf 20 jun 2019, tot en met 25 jun 2019, om 00:00, Vanaf <T> t/m <T+5>, 1 maal per dag 1 stuk, rectaal |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="4"|Toedieningsweg | | |colspan="4"|Toedieningsweg |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | + | |style="background-color: white;"|Rectaal (code = '12' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="4"|Doseerinstructie | | |colspan="4"|Doseerinstructie |
− | |style="background-color: white;"|1 maal per dag 2 stuks | + | |style="background-color: white;"|1 maal per dag 1 stuk |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Relatie naar medicatieafspraak
| |
− | |style="background-color: white;"|MBH_MO_123_3_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="5"|MBH identificatie | | |colspan="5"|MBH identificatie |
− | |style="background-color: white;"|MBH_MO_123_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_VO_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatie gebruik
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="4" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_3_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Registratiedatum
| |
− | |style="background-color: white;"|T, om 12:58
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruik indicator
| |
− | |style="background-color: white;"|Ja
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksperiode
| |
− | |style="background-color: white;"|Vanaf T- 10 dagen, tot en met T+ 1 dag, om 23:59
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Geneesmiddel - Product specificatie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="2"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Product naam
| |
− | |style="background-color: white;"|Glimepiride
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T- 10 dagen, tot en met T+ 1 dag, om 23:59, 1 maal per dag 1 tablet
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |style="background-color: white;"|Patiënt
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Kopie indicator
| |
− | |style="background-color: white;"|Ja
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}<section end=MBH_MBH_MO_123_3 /><section begin=MBH_MBH_MO_123_4 />
| |
− | ====Medicamenteuze behandeling MBH_MO_123_4 ====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="7" | Medicatieafspraak
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="6" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_4_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Afspraakdatum
| |
− | |style="background-color: white;"|T- 60 dagen, om 09:13
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Gebruiksperiode
| |
− | |style="background-color: white;"|Vanaf T- 60 dagen, tot nader order
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="7"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="10"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Zorgverlener
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="8"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Naamgegevens
| |
− | |style="background-color: white;"|I. Ternist
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Specialisme
| |
− | |style="background-color: white;"|Medisch specialisten, inwendige geneeskunde (code = '0313' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Zorgaanbieder
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgaanbieder identificatienummer
| |
− | |style="background-color: white;"|00001113 (in identificerend systeem: URA)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Organisatie naam
| |
− | |style="background-color: white;"|Antonius
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Adresgegevens
| |
− | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|INSULINE GLARGINE INJVLST 100E/ML (code = '121312' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|INSULINE GLARGINE INJVLST 100E/ML (code = '128651' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="7"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T- 60 dagen, tot nader order, 1 maal per dag 10IE, SUBCUTAAN
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Toedieningsweg
| |
− | |style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 10 internationale eenheid
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Kopie indicator
| |
− | |style="background-color: white;"|Ja
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
| |} | | |} |
| {| class="wikitable" width="85%" | | {| class="wikitable" width="85%" |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatieafspraak |
| |-style="background-color: #1F497D;; color: white; text-align:left;" | | |-style="background-color: #1F497D;; color: white; text-align:left;" |
| |colspan="5" width="25%"| Gegevenselement | | |colspan="5" width="25%"| Gegevenselement |
Regel 462: |
Regel 107: |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="5"|Identificatie | | |colspan="5"|Identificatie |
− | |style="background-color: white;"|MBH_MO_123_4_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_VO_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="5"|Afspraakdatum | | |colspan="5"|Afspraakdatum |
− | |style="background-color: white;"|T- 60 dagen, om 15:55 | + | |style="background-color: white;"|20 jun 2019, om 11:30 |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="5"|Gebruiksperiode | | |colspan="5"|Gebruiksperiode |
− | |style="background-color: white;"|Vanaf T- 60 dagen, tot nader order | + | |style="background-color: white;"|Vanaf 20 jun 2019, gedurende 3 weken |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="6"|Verstrekker | + | |colspan="6"|Voorschrijver |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |rowspan="5"| | + | |rowspan="11"| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="5"|Zorgaanbieder | + | |colspan="5"|Zorgverlener |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |rowspan="3"| | + | |rowspan="9"| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="3"|Zorgaanbieder identificatie nummer | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"|13336578 (in identificerend systeem: URA) | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="3"|Organisatie naam | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"|Poliapotheek Antonius | + | |style="background-color: white;"|Peter van Pulver |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="5"|Geneesmiddel - primaire code | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"|LANTUS SOLOSTAR INJ 100E/ML PEN 3ML (code = '1859226' in codeSystem 'G-Standaard HPK') | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|INSULINE GLARGINE INJVLST 100E/ML (code = '121312' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|INSULINE GLARGINE INJVLST 100E/ML (code = '128651' in codeSystem 'G-Standaard GPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="6"|Gebruiksinstructie | + | |colspan="4"|Zorgaanbieder |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |rowspan="4"| | | |rowspan="4"| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Omschrijving | + | |colspan="2"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"|Vanaf T- 60 dagen, tot nader order, Elke dag om 9 uur 10IE, subcutaan | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Toedieningsweg | + | |colspan="2"|Organisatie naam |
− | |style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Doseerinstructie | + | |colspan="2"|Adresgegevens |
− | |style="background-color: white;"|elke dag om 10 internationale eenheid
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Kopie indicator
| |
− | |style="background-color: white;"|Ja
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Relatie naar medicatieafspraak
| |
− | |style="background-color: white;"|MBH_MO_123_4_MA_1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}<section end=MBH_MBH_MO_123_4 /><section begin=MBH_MBH_MO_123_5 />
| |
− | ====Medicamenteuze behandeling MBH_MO_123_5 ====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Toedieningsafspraak | |
− | |-style="background-color: #1F497D;; color: white; text-align:left;" | |
− | |colspan="5" width="25%"| Gegevenselement | |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_5_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Afspraakdatum
| |
− | |style="background-color: white;"|T- 36 dagen, om 15:55
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Gebruiksperiode
| |
− | |style="background-color: white;"|Vanaf T- 36 dagen, gedurende 90 dagen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="5"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Zorgaanbieder
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgaanbieder identificatie nummer
| |
− | |style="background-color: white;"|13336578 (in identificerend systeem: URA)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Organisatie naam
| |
− | |style="background-color: white;"|Poliapotheek Antonius
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="5"|Geneesmiddel - primaire code | | |colspan="5"|Geneesmiddel - primaire code |
− | |style="background-color: white;"|PERINDOPRIL TERT-BUTYLAMINE GLENMARK TABLET 8MG (code = '2105594' in codeSystem 'G-Standaard HPK') | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="5"|Geneesmiddel - generiekere code | | |colspan="5"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"|PERINDOPRIL TABLET 8MG (ERBUMINE) (code = '69523' in codeSystem 'G-Standaard PRK') | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|PERINDOPRIL TABLET 8MG (ERBUMINE) (code = '117722' in codeSystem 'G-Standaard GPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="6"|Gebruiksinstructie | | |colspan="6"|Gebruiksinstructie |
Regel 561: |
Regel 156: |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="4"|Omschrijving | | |colspan="4"|Omschrijving |
− | |style="background-color: white;"|Vanaf T- 36 dagen, gedurende 90 dagen, 1 maal per dag 1 tablet, oraal | + | |style="background-color: white;"|Vanaf 20 jun 2019, gedurende 3 weken, Vanaf <T>, gedurende 3 weken, 1 maal per dag 1 stuk, oraal |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="4"|Toedieningsweg | | |colspan="4"|Toedieningsweg |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="4"|Doseerinstructie | | |colspan="4"|Doseerinstructie |
| |style="background-color: white;"|1 maal per dag 1 stuk | | |style="background-color: white;"|1 maal per dag 1 stuk |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Kopie indicator
| |
− | |style="background-color: white;"|Ja
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="5"|MBH identificatie | | |colspan="5"|MBH identificatie |
− | |style="background-color: white;"|MBH_MO_123_5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_VO_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| |} | | |} |
| {| class="wikitable" width="85%" | | {| class="wikitable" width="85%" |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatie gebruik | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatieafspraak |
| |-style="background-color: #1F497D;; color: white; text-align:left;" | | |-style="background-color: #1F497D;; color: white; text-align:left;" |
− | |colspan="4" width="25%"| Gegevenselement | + | |colspan="5" width="25%"| Gegevenselement |
| || Waarde | | || Waarde |
| | | |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Identificatie | + | |colspan="5"|Identificatie |
− | |style="background-color: white;"|MBH_MO_123_5_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | + | |style="background-color: white;"|MBH_VO_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Registratiedatum | + | |colspan="5"|Afspraakdatum |
− | |style="background-color: white;"|T- 33 dagen, om 13:58 | + | |style="background-color: white;"|20 jun 2019, om 11:32 |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Gebruik indicator | + | |colspan="5"|Gebruiksperiode |
− | |style="background-color: white;"|Nee
| + | |style="background-color: white;"|Vanaf 20 jun 2019, tot nader order |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Volgens afspraak indicator
| |
− | |style="background-color: white;"|Nee
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gebruiksperiode
| |
− | |style="background-color: white;"|Vanaf T- 34 dagen, tot nader order | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Stoptype
| |
− | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|PERINDOPRIL TERT-BUTYLAMINE GLENMARK TABLET 8MG (code = '2105594' in codeSystem 'G-Standaard HPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|PERINDOPRIL TABLET 8MG (ERBUMINE) (code = '69523' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|PERINDOPRIL TABLET 8MG (ERBUMINE) (code = '117722' in codeSystem 'G-Standaard GPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="5"|Gebruiksinstructie | + | |colspan="6"|Voorschrijver |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |rowspan="2"| | + | |rowspan="11"| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T- 34 dagen, tot nader order, gestaakt
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gerelateerde afspraak : TA
| |
− | |style="background-color: white;"|MBH_MO_123_5_TA_1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |style="background-color: white;"|Patiënt
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Reden wijzigen of stoppen gebruik
| |
− | |style="background-color: white;"|Te sterk effect (code = '6' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.2')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Kopie indicator
| |
− | |style="background-color: white;"|Ja
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Toelichting
| |
− | |style="background-color: white;"|Gestopt vanwege bijwerkingen
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}<section end=MBH_MBH_MO_123_5 /><section begin=MBH_MBH_MO_123_6 />
| |
− | ====Medicamenteuze behandeling MBH_MO_123_6 ====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="7" | Medicatieafspraak
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="6" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_6_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Afspraakdatum
| |
− | |style="background-color: white;"|T- 728 dagen, om 09:13
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Gebruiksperiode
| |
− | |style="background-color: white;"|Vanaf T- 728 dagen, tot nader order
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="7"|Voorschrijver | + | |colspan="5"|Zorgverlener |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |rowspan="10"| | + | |rowspan="9"| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Zorgverlener
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |rowspan="8"| | + | |colspan="3"|Zorgverlener identificatienummer |
| + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Naamgegevens | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"|John de Vries | + | |style="background-color: white;"|Peter van Pulver |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Specialisme | + | |colspan="3"|Specialisme |
| |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') | | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))') |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="5"|Zorgaanbieder | + | |colspan="4"|Zorgaanbieder |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |rowspan="4"| | | |rowspan="4"| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="3"|Zorgaanbieder identificatienummer | + | |colspan="2"|Zorgaanbieder identificatienummer |
| |style="background-color: white;"|00001111 (in identificerend systeem: URA) | | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="3"|Organisatie naam | + | |colspan="2"|Organisatie naam |
| |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="3"|Adresgegevens | + | |colspan="2"|Adresgegevens |
| |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|Simvastine tablet fo 20 mg (code = '67814' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|Simvastine tablet fo 20 mg (code = '116580' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="7"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T- 728 dagen, tot nader order, 1 maal per dag 1 tablet 's avonds, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk 's avonds
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Kopie indicator
| |
− | |style="background-color: white;"|Ja
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Toedieningsafspraak
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="5" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− |
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_6_TA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Afspraakdatum
| |
− | |style="background-color: white;"|T- 323 dagen, om 15:55
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Gebruiksperiode
| |
− | |style="background-color: white;"|Vanaf T- 323 dagen, tot nader order
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="5"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Zorgaanbieder
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgaanbieder identificatie nummer
| |
− | |style="background-color: white;"|13336578 (in identificerend systeem: URA)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Organisatie naam
| |
− | |style="background-color: white;"|Poliapotheek Antonius
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="5"|Geneesmiddel - primaire code | | |colspan="5"|Geneesmiddel - primaire code |
− | |style="background-color: white;"|SIMVASTATINE APOTEX TABLET FILMOMHULD 10MG (code = '1537792' in codeSystem 'G-Standaard HPK') | + | |style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|Simvastine tablet fo 20 mg (code = '67814' in codeSystem 'G-Standaard PRK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="5"|Geneesmiddel - generiekere code | | |colspan="5"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"|Simvastine tablet fo 20 mg (code = '116580' in codeSystem 'G-Standaard GPK') | + | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="6"|Gebruiksinstructie | | |colspan="6"|Gebruiksinstructie |
Regel 748: |
Regel 224: |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="4"|Omschrijving | | |colspan="4"|Omschrijving |
− | |style="background-color: white;"|Vanaf T- 323 dagen, tot nader order, 1 maal per dag 2 tabletten 's avonds, oraal | + | |style="background-color: white;"|Vanaf 20 jun 2019, tot nader order, Vanaf <T>, tot nader order, 1 maal per dag 1 stuk, oraal |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="4"|Toedieningsweg | | |colspan="4"|Toedieningsweg |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="4"|Doseerinstructie | | |colspan="4"|Doseerinstructie |
− | |style="background-color: white;"|1 maal per dag 2 stuks 's avonds | + | |style="background-color: white;"|1 maal per dag 1 stuk |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Kopie indicator
| |
− | |style="background-color: white;"|Ja
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Relatie naar medicatieafspraak
| |
− | |style="background-color: white;"|MBH_MO_123_6_MA_1
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| |colspan="5"|MBH identificatie | | |colspan="5"|MBH identificatie |
− | |style="background-color: white;"|MBH_MO_123_6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_VO_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |}<section end=MA_Basis patient A /> |
| + | ===Verstrekkingsverzoeken Basis patient A === |
| + | <section begin=VV_Basis patient A /> |
| {| class="wikitable" width="85%" | | {| class="wikitable" width="85%" |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatie gebruik | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Verstrekkingsverzoek |
| |-style="background-color: #1F497D;; color: white; text-align:left;" | | |-style="background-color: #1F497D;; color: white; text-align:left;" |
− | |colspan="4" width="25%"| Gegevenselement | + | |colspan="2" width="25%"| Gegevenselement |
| || Waarde | | || Waarde |
| | | |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Identificatie | + | |colspan="2"|Identificatie |
− | |style="background-color: white;"|MBH_MO_123_6_MGB_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | + | |style="background-color: white;"|MBH_VO_start_eind_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Registratiedatum | + | |colspan="2"|Datum |
− | |style="background-color: white;"|T- 248 dagen, om 09:00 | + | |style="background-color: white;"|20 jun 2019, om 11:25 |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Gebruik indicator | + | |colspan="2"|Auteur |
− | |style="background-color: white;"|Ja | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Volgens afspraak indicator | + | |colspan="2"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"|Nee | + | |style="background-color: white;"|5 stuks |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Gebruiksperiode | + | |colspan="2"|Geneesmiddel - primaire code |
− | |style="background-color: white;"|Vanaf T- 248 dagen, tot nader order | + | |style="background-color: white;"|Metoclopramide zetpil 20mg (code = '6939' in codeSystem 'G-Standaard PRK') |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Geneesmiddel - primaire code | + | |colspan="2"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"|SIMVASTATINE APOTEX TABLET FILMOMHULD 10MG (code = '1537792' in codeSystem 'G-Standaard HPK') | + | |style="background-color: white;"|METOCLOPRAMIDE 20MG ZETPIL (code = '63630' in codeSystem 'G-Standaard GPK') |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Geneesmiddel - generiekere code | + | |colspan="2"|Beoogd verstrekker |
− | |style="background-color: white;"|Simvastine tablet fo 20 mg (code = '67814' in codeSystem 'G-Standaard PRK')
| + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|Simvastine tablet fo 20 mg (code = '116580' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T- 248 dagen, tot nader order, 1 maal per dag 1 tablet 's avonds, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk 's avonds
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |style="background-color: white;"|Zorgverlener : I. Ternist - Medisch specialisten, inwendige geneeskunde. Antonius
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Kopie indicator | + | |colspan="2"|Relatie naar medicatieafspraak |
− | |style="background-color: white;"|Nee | + | |style="background-color: white;"|MBH_VO_start_eind_MA |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Toelichting | + | |colspan="2"|MBH identificatie |
− | |style="background-color: white;"|Patiënt gebruikt niet volgens voorschrift
| + | |style="background-color: white;"|MBH_VO_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
| |} | | |} |
| {| class="wikitable" width="85%" | | {| class="wikitable" width="85%" |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatie gebruik | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Verstrekkingsverzoek |
| |-style="background-color: #1F497D;; color: white; text-align:left;" | | |-style="background-color: #1F497D;; color: white; text-align:left;" |
− | |colspan="4" width="25%"| Gegevenselement | + | |colspan="2" width="25%"| Gegevenselement |
| || Waarde | | || Waarde |
| | | |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Identificatie | + | |colspan="2"|Identificatie |
− | |style="background-color: white;"|MBH_MO_123_6_MGB_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | + | |style="background-color: white;"|MBH_VO_start_duur_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Registratiedatum | + | |colspan="2"|Datum |
− | |style="background-color: white;"|T- 172 dagen, om 15:37 | + | |style="background-color: white;"|20 jun 2019, om 11:30 |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Gebruik indicator | + | |colspan="2"|Auteur |
− | |style="background-color: white;"|Ja | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Volgens afspraak indicator | + | |colspan="2"|Te verstrekken hoeveelheid |
− | |style="background-color: white;"|Nee | + | |style="background-color: white;"|21 stuks |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Gebruiksperiode | + | |colspan="2"|Geneesmiddel - primaire code |
− | |style="background-color: white;"|Vanaf T- 248 dagen, tot en met T- 173 dagen, om 23:59 | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Geneesmiddel - primaire code | + | |colspan="2"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"|SIMVASTATINE APOTEX TABLET FILMOMHULD 10MG (code = '1537792' in codeSystem 'G-Standaard HPK') | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Geneesmiddel - generiekere code | + | |colspan="2"|Beoogd verstrekker |
− | |style="background-color: white;"|Simvastine tablet fo 20 mg (code = '67814' in codeSystem 'G-Standaard PRK') | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Geneesmiddel - generiekere code | + | |colspan="2"|Relatie naar medicatieafspraak |
− | |style="background-color: white;"|Simvastine tablet fo 20 mg (code = '116580' in codeSystem 'G-Standaard GPK') | + | |style="background-color: white;"|MBH_VO_start_duur_MA |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Gebruiksinstructie
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |rowspan="4"|
| + | |colspan="2"|MBH identificatie |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| + | |style="background-color: white;"|MBH_VO_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |colspan="3"|Omschrijving | + | |} |
− | |style="background-color: white;"|Vanaf T- 248 dagen, tot en met T- 173 dagen, om 23:59, 1 maal per dag 1 tablet 's avonds, oraal, gestopt
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk 's avonds
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Gerelateerde afspraak : MA
| |
− | |style="background-color: white;"|MBH_MO_123_6_MA_1
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Auteur
| |
− | |style="background-color: white;"|Patiënt
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Toelichting
| |
− | |style="background-color: white;"|Veel last van jeuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
− | |}<section end=MBH_MBH_MO_123_6 /><section begin=MBH_MBH_MO_123_7 /> | |
− | ====Medicamenteuze behandeling MBH_MO_123_7 ====
| |
− | | |
| {| class="wikitable" width="85%" | | {| class="wikitable" width="85%" |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="7" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="3" | Verstrekkingsverzoek |
| |-style="background-color: #1F497D;; color: white; text-align:left;" | | |-style="background-color: #1F497D;; color: white; text-align:left;" |
− | |colspan="6" width="25%"| Gegevenselement | + | |colspan="2" width="25%"| Gegevenselement |
| || Waarde | | || Waarde |
| | | |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="6"|Identificatie | + | |colspan="2"|Identificatie |
− | |style="background-color: white;"|MBH_MO_123_7_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_VO_chronisch_VV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="6"|Afspraakdatum | + | |colspan="2"|Datum |
− | |style="background-color: white;"|T+ 3 dagen, om 09:27 | + | |style="background-color: white;"|20 jun 2019, om 11:32 |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="6"|Gebruiksperiode | + | |colspan="2"|Auteur |
− | |style="background-color: white;"|Vanaf T+ 3 dagen, tot en met T+ 17 dagen, om 23:59 | + | |style="background-color: white;"|Peter van Pulver - Huisartsen, niet nader gespecificeerd. Huisartsenpraktijk Pulver & Partners |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="7"|Voorschrijver
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |rowspan="10"| | + | |colspan="2"|Te verstrekken hoeveelheid |
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |style="background-color: white;"|21 stuks |
− | |colspan="6"|Zorgverlener
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |rowspan="8"| | + | |colspan="2"|Geneesmiddel - primaire code |
| + | |style="background-color: white;"|APACOF 250/250/50MG TABLET (code = '3891' in codeSystem 'G-Standaard PRK') |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Naamgegevens | + | |colspan="2"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"|John de Vries | + | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="4"|Specialisme | + | |colspan="2"|Beoogd verstrekker |
− | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))')
| + | |style="background-color: white;"|Apotheek De Gulle Gaper |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Zorgaanbieder
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgaanbieder identificatienummer
| |
− | |style="background-color: white;"|00001111 (in identificerend systeem: URA)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Organisatie naam
| |
− | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Adresgegevens
| |
− | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|Flucloxacilline capsule 500mg (code = '5274' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|Flucloxacilline capsule 500mg (code = '15466' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="7"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T+ 3 dagen, tot en met T+ 17 dagen, om 23:59, Elke 8 uur 1 capsule, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Kopie indicator
| |
− | |style="background-color: white;"|Ja
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_7 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}<section end=MBH_MBH_MO_123_7 /><section begin=MBH_MBH_MO_123_8 />
| |
− | ====Medicamenteuze behandeling MBH_MO_123_8 ====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Toedieningsafspraak
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="5" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_8_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Afspraakdatum
| |
− | |style="background-color: white;"|T- 28 dagen, om 11:50
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Gebruiksperiode
| |
− | |style="background-color: white;"|Vanaf T- 45 dagen, tot en met T- 29 dagen, om 23:59
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Stoptype
| |
− | |style="background-color: white;"|Onderbreking (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="5"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Zorgaanbieder
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgaanbieder identificatie nummer
| |
− | |style="background-color: white;"|13336578 (in identificerend systeem: URA)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Organisatie naam
| |
− | |style="background-color: white;"|Poliapotheek Antonius | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Reden afspraak
| |
− | |style="background-color: white;"|Beleidswijziging
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|Atorvastatine ranbaxy tablet filmomhuld 40 mg (code = '2230879' in codeSystem 'G-Standaard HPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|ATORVASTATINE TABLET 40MG (ALS CA-ZOUT-3-WATER) (code = '98620' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|ATORVASTATINE TABLET 40MG (ALS CA-ZOUT-3-WATER) (code = '137219' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T- 45 dagen, tot en met T- 29 dagen, om 23:59, 1 maal per dag 2 tabletten 's avonds, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 2 stuks 's avonds
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Kopie indicator
| |
− | |style="background-color: white;"|Ja
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Relatie naar medicatieafspraak
| |
− | |style="background-color: white;"|MBH_MO_123_8_MA_3
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_8 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}<section end=MBH_MBH_MO_123_8 /><section begin=MBH_MBH_MO_123_9 />
| |
− | ====Medicamenteuze behandeling MBH_MO_123_9 ====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="7" | Medicatieafspraak
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="6" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_9_MA_1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Afspraakdatum
| |
− | |style="background-color: white;"|T- 45 dagen, om 11:50
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Gebruiksperiode
| |
− | |style="background-color: white;"|Vanaf T- 45 dagen, tot en met T- 31 dagen, om 23:59
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="7"|Voorschrijver
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="10"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Zorgverlener
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="8"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Naamgegevens
| |
− | |style="background-color: white;"|John de Vries
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Specialisme
| |
− | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT (Vektis Zorgverlenersspecificatie (subberoepsgroep))')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Zorgaanbieder
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgaanbieder identificatienummer
| |
− | |style="background-color: white;"|00001111 (in identificerend systeem: URA)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Organisatie naam
| |
− | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Adresgegevens
| |
− | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|FLUCLOXACILLINE CAPSULE 500MG (code = '5274' in codeSystem 'G-Standaard PRK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Geneesmiddel - generiekere code
| |
− | |style="background-color: white;"|FLUCLOXACILLINE CAPSULE 500MG (code = '15466' in codeSystem 'G-Standaard GPK')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="7"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T- 45 dagen, tot en met T- 31 dagen, om 23:59, 1 keer per exact 8 uur 1 stuk, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Doseerinstructie
| |
− | |style="background-color: white;"|exact iedere 8 uur 1 stuk
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Kopie indicator
| |
− | |style="background-color: white;"|Ja
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_9 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1)
| |
− | |}<section end=MBH_MBH_MO_123_9 /><section begin=MBH_MBH_MO_123_10 />
| |
− | ====Medicamenteuze behandeling MBH_MO_123_10 ====
| |
− | | |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Toedieningsafspraak
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="5" width="25%"| Gegevenselement
| |
− | || Waarde
| |
− | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_10_TA_2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Afspraakdatum
| |
− | |style="background-color: white;"|T- 36 dagen, om 15:50
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Gebruiksperiode
| |
− | |style="background-color: white;"|Vanaf T- 56 dagen, tot en met T- 37 dagen, om 23:59
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Stoptype
| |
− | |style="background-color: white;"|Staking (code = '2' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="6"|Verstrekker
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="5"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Zorgaanbieder
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="3"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Zorgaanbieder identificatie nummer
| |
− | |style="background-color: white;"|13336578 (in identificerend systeem: URA)
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="3"|Organisatie naam
| |
− | |style="background-color: white;"|Poliapotheek Antonius
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Reden afspraak
| |
− | |style="background-color: white;"|Geen of onvoldoende effect
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Geneesmiddel - primaire code
| |
− | |style="background-color: white;"|PERINDOPRIL TERT-BUTYLAMINE GLENMARK TABLET 4MG (code = '2105586' in codeSystem 'G-Standaard HPK')
| |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="5"|Geneesmiddel - generiekere code | + | |colspan="2"|Relatie naar medicatieafspraak |
− | |style="background-color: white;"|PERINDOPRIL TABLET 4MG (ERBUMINE) (code = '29076' in codeSystem 'G-Standaard PRK') | + | |style="background-color: white;"|MBH_VO_chronisch_MA |
| |-style="vertical-align:top; background-color: #E3E3E3;;" | | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |colspan="5"|Geneesmiddel - generiekere code | + | |colspan="2"|MBH identificatie |
− | |style="background-color: white;"|PERINDOPRIL TABLET 4MG (ERBUMINE) (code = '75434' in codeSystem 'G-Standaard GPK')
| + | |style="background-color: white;"|MBH_VO_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| + | |}<section end=VV_Basis patient A /> |
− | |colspan="6"|Gebruiksinstructie
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |rowspan="4"|
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Omschrijving
| |
− | |style="background-color: white;"|Vanaf T- 56 dagen, tot en met T- 37 dagen, om 23:59, 1 maal per dag 1 tablet 's morgens, oraal
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Toedieningsweg
| |
− | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)')
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="4"|Doseerinstructie
| |
− | |style="background-color: white;"|1 maal per dag 1 stuk 's ochtends
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|Kopie indicator
| |
− | |style="background-color: white;"|Ja
| |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="5"|MBH identificatie
| |
− | |style="background-color: white;"|MBH_MO_123_10 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
− | |}<section end=MBH_MBH_MO_123_10 /><section end=MBHS_XXX_Jangi /> | |
− | ===Versiehistorie===
| |
− | <section begin=versiehistorie />
| |
− | {| class="wikitable" width="85%"
| |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="2" | Versiegegevens
| |
− | |-style="background-color: #1F497D;; color: white; text-align:left;"
| |
− | |colspan="1" width="25%"| Datum
| |
− | || Beschrijving
| |
| | | |
− | |-style="vertical-align:top; background-color: #E3E3E3;;"
| |
− | |colspan="1"|26 aug 2019
| |
− | |style="background-color: white;"|[https://bits.nictiz.nl/browse/MM-477 Issue MM-477] - adressoort toegevoegd bij alle adressen
| |
− | |}
| |
− | <section end=versiehistorie />
| |
− |
| |
| [[Categorie:Kwalificatie]] | | [[Categorie:Kwalificatie]] |